MYB and lymphoid enhancer-binding factor-1 (LEF-1) cooperated in the prevention of apoptosis in the leukemia cells, and GSK3β inhibition was able to circumvent this anti-apoptotic pathway[178]. Here, MYB is linked to leukemia.